Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Titel:
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
Auteur:
Carden, Craig P. Sarker, Debashis Postel-Vinay, Sophie Yap, Timothy A. Attard, Gerthardt Banerji, Udai Garrett, Michelle D. Thomas, George V. Workman, Paul Kaye, Stan B. de Bono, Johann S.